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The enterochromaffin-like (ECL) cells, which are the predominant endocrine
cell type in the acid-producing part ofthe vertebrate stomach, are characterized
by numerous, electron-lucent vesicles and few electron-dense granules in the
cytoplasm. The biological and physiological significance of the ECL cells
remains poorly understood. They produce and store histamine and pancreastatin
and are thought to produce an as yet unidentified peptide hormone. The most
important clue to their function is their willingness to respond to changes in cir-
culating gastrin. The present review presents current knowledge of the biology
and physiology ofthe rat stomach ECL cells.
Examination of serially sectioned ECL cells has revealed that the cytoplasmic
vesicles almost invariably contain an electron-dense core, suggesting that per-
haps the distinction between granules and vesicles is artificial. We propose a
life cycle of the secretory organelles in the ECL cells with a progressive devel-
opment from granules to vesicles. The results showed that the gastrin-evoked
release of histamine and pancreastatin was accompanied by loss of vesicles,
and that synthesis of histamine and pancreastatin was accelerated by sustained
infusion of gastrin, a treatment that was associated with renewal of vesicles.
The events described are instrumental in bringing about a change in the "steady
state" or "equilibrium" ofthe ECL cells, from a non-stimulated, resting state to
a gastrin-stimulated, active state. This change is attained within six to eight hr.
The next "steady state" change is that from "normal-sized" but active ECL cells
to "hypertrophic" ECL cells. The increase in cell size is complete after about
one week. The gastrin-evoked increase in the ECL cell self-replication rate is
maximal after about 10 days, after which time there is a gradual return back to
pre-stimulation values. The ECL cell density increases fairly slowly and does
not reach maximum (four-fold increase) until after 20 weeks of hypergastrine-
mia. The activity of the histamine-forming enzyme, histidine decarboxylase, is
elevated by gastrin and remains elevated for as long as the gastrin stimulus is
maintained (the longest time studied was 20 weeks).
The physiological significance of the ECL cells is probably related to their
capacity to produce and store histamine and an as yet unidentified peptide hor-
mone. The ECL cells are thought to be the source of histamine necessary for
the gastrin-evoked acid response. In addition, preliminary evidence suggests
that the ECL cells and the anticipated ECL cell hormone play a role in bone
formation.
aTo whom all correspondence should be addressed: Professor Rolf Hakanson, Dept. of
Pharmacology, University ofLund, Solvegatan 10, S-223 62 Lund, Sweden. Tel: (46) 46-2227585;
Fax: (46) 46-104429; E-mail: farm@farm.lu.se.
dAbbreviations: ECL, enterochromaffin-like (cells); HDC, histidine decarboxylase; 5-HT, 5-
hydroxytryptamine; a-FMH, a-fluoromethylhistidine; LI, labelling index.
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INTRODUCTION
The so-called enterochromaffin-like (ECL)d cells have attracted much attention in
recent years. Nonetheless, their physiological significance remains poorly understood.
They are histamine-producing and peptide-hormone-producing cells that occur exclusive-
ly in the acid-producing gastric mucosa [1-5]. Several different endocrine cell types can
be demonstrated in this location [6-9]. Together they represent about two percent of the
cells in the acid-producing mucosa of the rat; the corresponding figure in man is 0.5 to
one percent. This means that the endocrine cells in the acid-producing mucosa constitute
an endocrine organ that is about equal in size to the endocrine pancreas. In the rat, the
ECL cells comprise at least 65 percent of the endocrine cells [5, 7], the corresponding
figure in man is 30-35 percent [7]. The ECL cells can be demonstrated-albeit not selec-
tively-by silver-staining techniques and also by immunocytochemistry, taking advan-
tage of the fact that they contain histamine and the histamine-forming enzyme, histidine
decarboxylase (HDC). In mammals, they occur predominantly in the basal half, some-
times in the basal third, ofthe acid-producing mucosa in the chief-cell-rich region.
ULTRASTRUCTURAL FEATURES OF THE ECL CELL
The ECL cells are best defined by their characteristic ultrastructure [1, 2, 6, 8, 9].
They are irregular in shape, often displaying prominent extensions, and they contain elec-
tron-dense granules and electron-lucent vesicles (Figure 1). The ultrastructure of the ECL
cells distiguishes them from all other endocrine cell types in the gastric mucosa. Besides
histamine and the anticipated peptide hormone, the ECL cells produce chromogranin A,
which is a member of the chromogranin/secretogranin family and occurs in many peptide
hormone-producing cells [10-15]. Chromogranin A and its cleavage products are co-
stored with biogenic amines and regulatory peptides and are thought to play a role in the
formation and stabilization of secretory granules [15]. Chromogranin A is proteolytically
processed to yield fragments, one such fragment is pancreastatin, which has been demon-
strated in the ECL cells [10].
The cytoplasmic vesicles in the ECL cells are numerous and of varying size, often
quite large; they are empty-looking or contain a small, eccentrically-located dense core
[16-18]. The granules are few and small in size and have a dense core that is separated
from the enclosing membrane by a thin electron-lucent halo. Examination of serially sec-
tioned ECL cells has revealed that the vesicles almost invariably contain an electron-
dense core (Figure 2), suggesting that perhaps the distinction between granules and vesi-
cles is artificial. We have argued previously that granules probably develop into vesicles
as a result ofprogressive accumulation ofpre-formed histamine from the cytoplasm and
that they grow in size during this process, possibly through osmotic forces generated by
the resulting high local concentration ofhistamine [17-18] (Figure 3).
If the histamine-containing ECL cells are exposed to exogenous 5-hydroxytrypto-
phan or DOPA, they are able to take up and decarboxylate these amino acids and to store
the resulting amine, 5-hydroxytryptamine (5-HT) or dopamine, in the cytoplasm [19].
Histochemistry at the electron microscopic level suggested that the newly formed amine
was in fact confined to the dense core of the granules and vesicles [1, 20]. Rubin and
Schwartz [21] used autoradiographic technique to show labelling of secretory organelles
in the ECL cells with 3H-5-HT after incubating tissue specimens with 3H-5-hydroxytryp-
tophan. In a subsequent study, Rubin and Schwartz [22] labelled ECL cells with 3H-histi-
dine. However, the labelling in the cytoplasm, which reflected the presence of 3H-his-
tamine, could not be convincingly associated with the vesicles. Using immunocytochem-
istry at the electron microscopic level, Delwaide et al. [23] recently demonstrated his-
tamine in ECL cell granules, while Nissinen and Panula [5] failed to do so. The failure to
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demonstrate histamine label or histamine immunostaining over granules and vesicles may
reflect diffusion of histamine from its subcellular storage site because of inadequate fixa-
tion and processing of the specimens. Although direct evidence for the storage of his-
tamine in the secretory organelles is still missing, available information seems to favour
the view that amine storage in the ECL cell is associated with granules and vesicles
(Figure 3).
Figure 1. Electron micrograph showing an ECL cell in rat stomach. Numerous electron-lucent
vesicles (indicated by arrows) and less numerous electron-dense granules (indicated by arrow-
heads) are typical features of the ECL cells. Vesicles are defined as cytoplasmic membrane-
enclosed organelles without dense core or possessing a small, often eccentrically-located dense
core, the diameter of the dense core being only a fraction of the diameter of the organelle. The
granules are defined as cytoplasmic membrane-enclosed organelles, furnished with an electron-
dense core and with a thin electron-lucent halo between the membrane and the dense core; the
diameter of the dense core represents 50 percent or more of the diameter of the entire organelle. It
cannot be excluded that granules and vesicles represent separate entities, but there have been grow-
ing suspicions for some time that there is a gradual transition from granules to vesicles (see text).
10,000 X.
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Figure 2. A series offour consecutive electron micrographs (1-4) of an ECL cell. Serially sec-
tioned vesicles are indicated by asterisk. Note that apparently "empty" vesicles usually turn out to
have an electron-dense core. 24,000 X.
IMMEDIATE RESPONSE OF THE ECL CELL TO GASTRIN
The ECL cells respond to gastrin according to a preset time table. An acute challenge
with maximal doses of gastrin in the form of a sustained intravenous infusion to con-
scious rats results in a prompt reduction ofthe number of vesicles per cell profile, lower-
ing of the concentration ofhistamine in the oxyntic mucosa (reflecting the release of his-
tamine [24]) (Figure 4) and release of pancreastatin [25] (Figure 5). Gastrin-evoked his-
tamine release has been observed also in isolated ECL cells [26]. Half an hour after the
start of gastrin infusion, approximately 50 percent of the vesicles had disappeared. It is
likely that the process of exocytosis explains the reduced number of vesicles and the
release of histamine and pancreastatin (Figure 3). Signs of exocytosis (omega figures)
were difficult to find, probably because the actual process of exocytosis is very brief
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Figure 3. Proposed life cycle ofECL cell granules and vesicles. The prohormone ofthe ECL cell
is synthesized in the rough endoplasmic reticulum (RER) together with chromogranin A and other
granular proteins. They are then transported to the Golgi region for packaging into the prosecretory
granules. The granules are small and electron-dense, and as they are transported away from the
Golgi area, they actively take up preformed histamine from the cytoplasm to become vesicles. At
the same time, chromogranin A is being hydrolyzed into small fragments, such as pancreastatin.
The vesicles grow in size during the process of histamine accumulation, possibly through osmotic
forces generated by the resulting high local concentration of histamine and peptide fragments.
When the ECL cells are activated by acute gastrin stimulation, histamine and pancreastatin (and the
anticipated hormone) in the vesicles are released via exocytosis. Following blockade of histamine
synthesis by a-FMH, the ECL cells are depleted ofhistamine, and the granules cannot accumulate
histamine. Hence, they cannot develop into vesicles. When histamine synthesis (and release) is
being continuously stimulated (e.g., by omeprazole-evoked hypergastrinemia), the vesicles become
large and numerous. In fact, very large vesicles are sometimes observed; they appear to be formed
by fusion ofsmaller vesicles.
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indeed. Within the first hour after the start of gastrin infusion the ECL cells begin to
adapt to the sustained stimulus. HDC and chromogranin A are now being synthesized at
an accelerated rate and the number of vesicles is increasing. The number of vesicles was
back to pre-stimulation values about four hr after start of gastrin infusion. The histamine
concentration was back to normal after three to four hr, and the pancreastatin concentra-
tion had returned to normal after four to six hr [26] (Figures 4 and 5). At this stage, a new
"steady state" seems to have been attained; the short-term responses have been dealt with,
and the cells have adjusted to the new situation ofamaintained gastrin stimulus.
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Figure 4. Time course of the changes in (A)
number of vesicles (open circles) and gran-
ules (filled circles) (expressed as number per
ECL cell profile) and in (B) histamine con-
centration (pg/g) in the oxyntic mucosa in
response to Leul5-gastrin-17 infusion (5
nmol/kg/hr, i.v.). Mean ± SEM (vertical bars, n
= 30-35 cells from 4-9 rats) [25].
Figure 5. Tlme course of (A) the rise in the
concentration of circulating pancreastatin
(pmol/l) and of (B) the reduction in the
oxyntic mucosal pancreastatin concentra-
tion (pmol/g) in response to Leul5-gastrin-
17 infusion (5 nmol/kg/hr, i.v.). Mean ±
SEM (vertical bars, n = 4-9 rats). The concen-
tration of pancreastatin was measured by
radioimmunoassay using antibodies against
the C-terminal decapeptide end of rat pan-
creastatin (chromogranin A 264-314-amide)
[25].
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The association between gastrin-stimulated degranulation on one hand and secretion
of histamine and pancreastatin on the other supports the view that the two secretory prod-
ucts are stored together in granules and/or vesicles. However, the reduction in mucosal
histamine did not completely parallel that of pancreastatin, in that the drop in histamine
occurred much sooner after start of gastrin infusion than did the drop in pancreastatin,
and in that mucosal histamine was replenished much faster than was pancreastatin [26].
Also, the release of pancreastatin into the circulation seemed to occur more slowly than
what has been described for histamine [24, 27]. These discrepancies may favour the view
that histamine and pancreastatin do not occur together in the same secretory organelles,
or that the two secretory products are co-stored but not necessarily in the same compart-
ment and/or not in fixed proportions. Secretory products in the resting ECL cell may
occur in two pools, one close to the cell membrane and immediately available for release
("mature" vesicles) and another restrained from contact with release sites in the cell
membrane, either by sheer distance or by the organization of the cytoskeleton (granules
and "immature" vesicles) (Figure 3). Conceivably, the readily releasable pool contains
proportionately more histamine than pancreastatin while the opposite is the case for the
reserve pool. It can be assumed that chromogranin A is deposited in the secretory
organelle at the time of its formation in the Golgi apparatus, whereas histamine is being
taken up preformed from the cytoplasm at a much later stage. Hence, it is to be expected
that the proportion of histamine versus chromogranin A-derived peptides (for instance
pancreastatin) may vary depending upon the age ofthe organelle.
Histamine is rapidly replenished as a result of the increased HDC activity. It has been
suggested that the release of histamine and the activation of HDC are coupled so that the
release of histamine triggers the activation of HDC and that the HDC activity is turned
off when the histamine stores have been replenished [28]. The present results show the
HDC activity to increase quite slowly at first; after 30-60 min of infusing gastrin the
enzyme activity started to increase more rapidly until reaching a plateau at six hr (Figure
6A). It should be noted that although the increase in HDC activity was initiated when the
histamine concentration in the oxyntic mucosa was lowered, it continued long after his-
tamine replenishment, suggesting that the activation of HDC is independent of the con-
centration ofhistamine, or perhaps more likely, that the activation of HDC is initiated by
the lowering of histamine (or by the combination of gastrin stimulation and lowering of
histamine) and maintained by gastrin stimulation.
The activation of HDC appears to be associated with a progressive increase in the
level of HDC mRNA (Figure 6B). Interestingly, the gastrin-evoked increase in HDC
mRNA was slower and less marked than the increase in HDC activity [25]. The activa-
tion of HDC is generally thought to reflect de novo synthesis of enzyme [29]. In view of
the relatively slow accumulation of HDC mRNA in the oxyntic mucosa in response to
gastrin, it may be argued either that preformed HDC may be transformed from inactive to
active enzyme or that existing HDC mRNA is rapidly and effectively translated into
enzyme. Conceivably, gastrin stimulates transcription as well as translation of the HDC
gene in the ECL cells.
LONG-TERM EFFECTS OF GASTRIN ON THE ECL CELL
Six hr after the start of gastrin infusion, the ECL cells are in an activated "steady
state," where nothing very dramatic seems to be going on. However, this impression is
probably deceptive since it is possible to detect an increase in the cell size and an
increased amount of endoplasmic reticulum and Golgi after about four to eight days of
continuous gastrin infusion [16, 18]. The cells remain enlarged for at least 28 days, the
longest time studied. The cytoplasmic vesicles display an altered appearance following a
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period of sustained hypergastrinemia. Many of them become very large, giving the
impression that they result from fusion ofseveral smaller vesicles [16] (Figure 3).
In the time course of events that takes place in the ECL cells in response to sustained
hypergastrinemia (whether of endogenous or exogenous origin) the next step is stimulat-
ed selfreplication [30]. The ECL cells are capable ofdividing, and although their mitotic
activity is low, it appears to be sufficient to maintain the ECL cell population. Sustained
elevation of the circulating gastrin levels, induced by gastrin infusion, by pharmacologi-
cal treatment with inhibitors ofacid secretion (omeprazole, ranitidine) or by surgery, e.g.,
partial removal of the acid-producing part ofthe stomach (partial fundectomy) or antrum
exclusion, stimulates mitosis in the ECL cells and induces hyperplasia [31-39]. The
labelling index (LI), i.e., the proportion of ECL cells that incorporate 3H-thymidine in
preparation for mitosis, is elevated almost 10-fold after about 10 days of omeprazole-
evoked hypergastrinemia, but this effect is transient; after 10 and 20 weeks, the LI is back
to pre-stimulation values in spite of the maintained hypergastrinemia [30] (Figure 7A).
The actual increase in the number of ECL cells in the oxyntic mucosa progressed quite
slowly by comparison and reached a maximum of about four-fold increase after 20 weeks
and up to 52 weeks ofhypergastrinemia [30] (Figure 7B). Interestingly, the HDC activity,
which is thought to reflect the functional activity of the ECL cells, still remained elevated
after 20 weeks (Figure 7C). The decline in ECL cell LI during long-term omeprazole-
evoked hypergastrinemia might reflect an impaired ability to respond to gastrin because
of receptor down-regulation or because of local accumulation of growth inhibitors [40].
The fact that the ability ofgastrin to activate HDC was not impaired indicates that gastrin
retains its ability to activate the ECL cells (reflected in HDC activities well above control
levels) at a stage when it had a reduced effect as a growth-stimulating factor (reflected in
a LI at control level). This could be interpreted to mean either that the gastrin receptor
responsible for the trophic response is distinct from the receptorresponsible for activating
the cells or that the gastrin-induced responses in the ECL cells are mediated via two inde-
pendent post-receptor pathways, one of which is off-set by a long-lasting gastrin chal-
lenge while the other is not.
PHYSIOLOGICAL SIGNIFICANCE OF THE ECL CELLS
It has turned out to be difficult to define what physiological role the ECL cells fulfill. The
most important clue to the function of the ECL cells is their willingness to respond to
changes in circulating gastrin. This feature has made the ECL cells the prime suspect for a
role as local supplier of histamine to stimulate the parietal cells. The significance of ECL
cell histamine can be studied by the use of a-fluoromethylhistidine (a-FMH) an irre-
versible inhibitor, a so-called suicide inhibitor, of HDC. Treatment of rats with a-FMH
results in irreversible inhibition of HDC and reduces the histamine concentration in the
oxyntic mucosa by about 80 percent [17, 41]. It could be shown by immunocytochemistry
that a-FMH depletes histamine from the ECL cells but not from the mast cells, which are
few in the oxyntic mucosa of the rat. Interestingly, histamine depletion was associated
with a marked loss of cytoplasmic vesicles, and the few that remained were quite small
[17, 41]. This observation supports the contention that granules develop into vesicles as a
result ofintragranular accumulation ofhistamine. Hence, itmight be speculated that gran-
ules are "young and immature" and that vesicles are more "mature" (Figure 3). ECL cell
histamine depletion has important functional consequences. Basal and gastrin-stimulated
acid secretion is suppressed while histamine- and vagally-stimulated acid secretion is
unaffected [42]. Histamine-depleted ECL cells were found to respond to the growth-stim-
ulating effects of gastrin much like normal ECL cells. Also, the gastrin-evoked growth of
the oxyntic mucosa was unaffected by depletion ofECL cell histamine [41].
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In a discussion of the biology of the ECL cells, it may be pertinent to point out that
the ECL cell hormone still remains to be identified. Hormone deprivation (i.e., gastrecto-
my) should be one way to identify the type of hormone produced by the ECL cells.
Gastrectomy has a number of quite dramatic consequences, some of which concern
impairment in bone architecture and a deficient calcium homeostasis. Thus, gastrectomy
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Figure 6. Time course ofthe rise in (A) HDC
activity (pmol CO2mg hr) and in (B) HDC
mRNA level (percent pre-stimulation) and B-
actin mRNA (a housekeeping gene) level
(percent pre-stimulation) in the oxyntic
mucosa in response to Leu15-gastrin-17 infu-
sion (5 nmol/kglhr, i.v.). Mean ± SEM (vertical
bars, n = 4-9 rats). The mRNAs for HDC and B-
actin were analyzed by Northern blot using 32p-
labelled cRNA probes; the levels were deter-
mined (semi-quantitatively) by densitometric
scanning after autoradiography [25].
Figure 7. Time course of the changes in (A)
ECL LI (percent), (B) ECL cell density
(number of cells per visual field) and (C)
HDC activity (pmol C02/mg hr) in the
oxyntic mucosa of omeprazole-treat-
ed(400pmol/kg/day, p.o.) (filled square) and
vehicle-treated (open circle) rats. Mean +
SEM (vertical bars, n = 7-10 rats). The ECL
cells were visualized by immunocytochem-
istry using histamine antibodies [30].
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caused rapid bone loss and a marked reduction in trabecular bone volume [43-45]. These
effects do not reflect the loss ofgastric acid since omeprazole-induced blockade ofgastric
acid secretion did not reproduce the efffects of gastrectomy. The gastrectomy-evoked
osteoporosis could be prevented only partly or not at all by supplementation with calcium
[44], and it cannot be excluded that the bone loss reflects a gastric hormone deficiency
rather than calcium deficiency. Moreover, gastrectomized rats respond to an oral CaCl2
load with a marked hypercalcemia, unlike intact rats that do not display any perturbation
of blood Ca2+ levels under identical circumstances (Hakanson, in preparation).
Conceivably, the acid-producing part of the stomach harbours an anti-hypercalcemic sig-
nal that can be released by gastrin. In addition, gastrectomy greatly aggravates the
hypocalcemia that ensues following parathyroidectomy [46]. The hypocalcemia evoked
by parathyroidectomy is thought to reflect a reduced turn-over of bone. Perhaps the com-
bination of gastrectomy and parathyroidectomy aggravates the impairment in bone turn-
over. Finally, gastrin stimulates the uptake of Ca2+ into bone and evokes a transient
hypocalcemic response, possibly reflecting the uptake of Ca2+ [47-50]. These effects of
gastrin are abolished by gastrectomy or fundectomy, suggesting that gastrin acts to release
a hypocalcemic agent from the acid-producing part of the stomach [49, 50]. This agent,
which has been referred to provisionally as gastrocalcin, may originate from the ECL
cells.
CONCLUDING COMMENTS
The histamine-producing ECL cells that are confined to the acid-producing part of
the stomach represent an endocrine organ of impressive size. It appears likely that the
ECL cells, which are highly responsive to gastrin, represent the local source of histamine
that participates in controlling the activity of the parietal cells. The peptide hormone of
the ECL cells has not yet been identified, but indirect evidence suggests that the ECL
cells (and the anticipated ECL cell hormone) play a role in controlling or directing bone
modelling and re-modelling.
Gastrin is said to have two physiologically important actions: stimulating acid secre-
tion and stimulating growth ofthe oxyntic mucosa, notably the ECL cells. The acid-stim-
ulating effect of gastrin seems to be largely mediated by the gastrin-induced release of
histamine from the ECL cells. In view ofthe powerful stimulating effect of gastrin on the
ECL cells, it is tempting to suggest that the primary effect of gastrin is to stimulate the
ECL cells and to cause secretion ofhistamine and the ECL cell hormone.
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